1887

n CME : Your SA Journal of CPD - Atopic eczema : current therapeutic advances : main article

Volume 23, Issue 9
  • ISSN : 0256-2170
USD

 

Abstract

Atopic eczema significantly affects the quality of life of sufferers. <br>There are good epidemiological data supporting the view that the prevalence is on the rise. The reasons for this are not clear. <br>A single treatment modality is not sufficient in controlling the disease. <br>The availability of new classes of drugs such as calcineurin inhibitors is a significant advance in the management of atopic eczema. <br>The calcineurin inhibitors can be used as first-line therapy for atopic eczema. <br>A comprehensive approach is required encompassing allergen avoidance, use of moisturisers, careful application of topical steroids and use of the recently available topical calcineurin inhibitors. <br>Most patients can be well controlled with a combination of these treatments.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_cme/23/9/EJC63022
2005-09-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error